Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125250491 | 12525049 | 1 | I | 20160114 | 20160624 | 20160704 | 20160704 | EXP | GB-MHRA-EYC 00141234 | GB-PFIZER INC-2016317389 | PFIZER | 46.00 | YR | F | Y | 65.77000 | KG | 20160704 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125250491 | 12525049 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | 200MG MORNING AND NIGHT, 100MG TEATIME (TITRATED UP SLOWLY THEN DOWN SLOWLY TO STOP) | N | M64841 | 20235 | ||||||||
| 125250491 | 12525049 | 2 | C | CODEINE PHOSPHATE | CODEINE PHOSPHATE | 1 | STOPPED AFTER TITRATING UP GABAPENTIN. | 0 | |||||||||||
| 125250491 | 12525049 | 3 | C | FYBOGEL MEBEVERINE | 2 | ONLY IN LAST 28 DAYS | 0 | ||||||||||||
| 125250491 | 12525049 | 4 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | RECENTLY STOPPED | 0 | |||||||||||
| 125250491 | 12525049 | 5 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125250491 | 12525049 | 1 | Intervertebral disc protrusion |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125250491 | 12525049 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125250491 | 12525049 | Disturbance in attention | |
| 125250491 | 12525049 | Dizziness | |
| 125250491 | 12525049 | Fatigue | |
| 125250491 | 12525049 | Feeling abnormal | |
| 125250491 | 12525049 | Flatulence | |
| 125250491 | 12525049 | Gastrointestinal motility disorder | |
| 125250491 | 12525049 | Memory impairment | |
| 125250491 | 12525049 | Speech disorder | |
| 125250491 | 12525049 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125250491 | 12525049 | 1 | 20160112 | 20160508 | 0 |